Cargando…

Maintenance Therapy With Interleukin-2 for Childhood AML: Results of ELAM02 Phase III Randomized Trial

Despite significant progress in the treatment of pediatric acute myeloblastic leukemia (AML), relapse remains the commonest cause of death. Randomized ELAM02 trial questioned if maintenance therapy with interleukin-2 (IL2), for 1 year, improves disease-free survival (DFS). Patients aged 0 to 18 year...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petit, Arnaud, Ducassou, Stéphane, Leblanc, Thierry, Pasquet, Marlène, Rousseau, Alexandra, Ragu, Christine, Cachanado, Marine, Nelken, Brigitte, Bertrand, Yves, Michel, Gérard, Gandemer, Virginie, Cuccuini, Wendy, Fenneteau, Odile, Lapillonne, Hélène, Auvrignon, Anne, Baruchel, André, Leverger, Guy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745961/ https://www.ncbi.nlm.nih.gov/pubmed/31723797 http://dx.doi.org/10.1097/HS9.0000000000000159

Ejemplares similares

Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study Group
por: Marceau-Renaut, Alice, et al.
Publicado: (2018)

Leukemia Cutis in Childhood Acute Myeloid Leukemia: Epidemiological, Clinical, Biological, and Prognostic Characteristics of Patients Included in the ELAM02 Study
por: Gouache, Elodie, et al.
Publicado: (2018)

Is Acute Myeloblastic Leukemia in Children Under 2 Years of Age a Specific Entity? A Report from the FRENCH ELAM02 Study Group
por: Blais, S., et al.
Publicado: (2019)

Germline pathogenic variants in transcription factors predisposing to pediatric acute myeloid leukemia: results from the French ELAM02 trial
por: Fenwarth, Laurène, et al.
Publicado: (2020)

Prognostic impact of RUNX1 mutations and deletions in pediatric acute myeloid leukemia: results from the French ELAM02 study group
por: Lew-Derivry, Lucille, et al.
Publicado: (2023)

Prognostic impact of ABCA3 expression in adult and pediatric acute myeloid leukemia: an ALFA-ELAM02 joint study
por: Ceraulo, Antony, et al.
Publicado: (2022)

Infant Acute Myeloid Leukemia: A Unique Clinical and Biological Entity
por: Calvo, Charlotte, et al.
Publicado: (2021)

Elam on Cerebria
Publicado: (1873)

2nd ELAM Conference
por: Bott, R, et al.
Publicado: (1972)

Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg(®)) in children with relapsed/refractory myeloid leukemia
por: Brethon, Benoit, et al.
Publicado: (2006)

COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE)
por: Baruchel, André, et al.
Publicado: (2020)

COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE)
por: Rouger-Gaudichon, Jérémie, et al.
Publicado: (2021)

ARID5B, IKZF1 and Non-Genetic Factors in the Etiology of Childhood Acute Lymphoblastic Leukemia: The ESCALE Study
por: Rudant, Jérémie, et al.
Publicado: (2015)

Household Exposure to Pesticides and Risk of Childhood Hematopoietic Malignancies: The ESCALE Study (SFCE)
por: Rudant, Jérémie, et al.
Publicado: (2007)

SNP-array lesions in core binding factor acute myeloid leukemia
por: Duployez, Nicolas, et al.
Publicado: (2018)

Bone Mineral Density Evolution and Its Determinants in Long-term Survivors of Childhood Acute Leukemia: A Leucémies Enfants Adolescents Study
por: Tabone, Marie-Dominique, et al.
Publicado: (2021)

The effects of platelet activating factor and retinoic acid on the expression of ELAM-1 and ICAM-1 and the functions of neutrophils
por: Chen, Si-Feng
Publicado: (1995)

Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study
por: Gandemer, Virginie, et al.
Publicado: (2009)

Day-care, early common infections and childhood acute leukaemia: a multicentre French case–control study
por: Perrillat, F, et al.
Publicado: (2002)

Childhood acute lymphoblastic leukaemia and indicators of early immune stimulation: the Estelle study (SFCE)
por: Ajrouche, R, et al.
Publicado: (2015)

Prevalence and characteristics of metabolic syndrome in adults from the French childhood leukemia survivors’ cohort: a comparison with controls from the French population
por: Oudin, Claire, et al.
Publicado: (2018)

Late effects in survivors of infantile acute leukemia: a study of the L.E.A program
por: Gandemer, V, et al.
Publicado: (2017)

Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL
por: Simonin, Mathieu, et al.
Publicado: (2021)

Biallelic CXCR2 loss-of-function mutations define a distinct congenital neutropenia entity
por: Marin-Esteban, Viviana, et al.
Publicado: (2021)

A cohort of French pediatric patients with primary immunodeficiencies: are patient preferences regarding replacement immunotherapy fulfilled in real-life conditions?
por: Pasquet, Marlène, et al.
Publicado: (2017)

French “real life” experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia
por: Trioche, Pascale, et al.
Publicado: (2012)

Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia
por: Brethon, Benoît, et al.
Publicado: (2021)

Road Traffic and Childhood Leukemia: The ESCALE Study (SFCE)
por: Amigou, Alicia, et al.
Publicado: (2011)

Germline RUNX1 variants in paediatric patients in a French specialised centre
por: Liu, Cécile, et al.
Publicado: (2022)

Novel Insights into Pediatric Acute Lymphoblastic Leukemia Ophthalmic Relapses from a Nationwide Cohort Study
por: Le Louet, Solenne, et al.
Publicado: (2022)

Parental reassurance concerning a feverish child: determinant factors in rural general practice
por: Chapron, Anthony, et al.
Publicado: (2018)

Four molecular pathways of T cell adhesion to endothelial cells: roles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions
Publicado: (1991)

Five distinct biological processes and 14 differentially expressed genes characterize TEL/AML1-positive leukemia
por: Gandemer, Virginie, et al.
Publicado: (2007)

Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE)
por: Donadieu, J, et al.
Publicado: (2000)

Bone Marrow Clonogenic Myeloid Progenitors from NPM1-Mutated AML Patients Do Not Harbor the NPM1 Mutation: Implication for the Cell-Of-Origin of NPM1+ AML
por: Diaz de la Guardia, Rafael, et al.
Publicado: (2020)

Thymus and Mediastinal Node Involvement in Childhood Langerhans Cell Histiocytosis: Long-Term Follow-Up From the French National Cohort
por: Ducassou, Stephane, et al.
Publicado: (2013)

Engraftment characterization of risk-stratified AML in NSGS mice
por: Díaz de la Guardia, Rafael, et al.
Publicado: (2021)

Determination of differentially regulated proteins upon proteasome inhibition in AML cell lines by the combination of large‐scale and targeted quantitative proteomics
por: Matondo, Mariette, et al.
Publicado: (2016)

Congenital neutropenia: diagnosis, molecular bases and patient management
por: Donadieu, Jean, et al.
Publicado: (2011)

When Ring Sideroblasts on Bone Marrow Smears Are Inconsistent with the Diagnosis of Myelodysplastic Neoplasms
por: Girard, Sandrine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dmop5vvfo6usu1ebtra95mhn5j